Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Celyad SA (CLYYF)
OTHER OTC:CLYYF
Holding CLYYF?
Track your performance easily
CLYYF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.25 - $0.78
Previous Close$0.25
Volume500.00
Average Volume (3M)500.00
Market Cap
$11.45M
Enterprise Value-$698.85K
Total Cash (Recent Filing)$12.40M
Total Debt (Recent Filing)$255.00K
Price to Earnings (P/E)―
Beta0.61
Next Earnings
Nov 07, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.26
Shares Outstanding22,593,956
10 Day Avg. Volume0
30 Day Avg. Volume500
Standard Deviation0.35
R-Squared0.04
Alpha-0.08
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.04
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CLYYF FAQ
What was Celyad SA’s price range in the past 12 months?
Celyad SA lowest stock price was $0.24 and its highest was $0.78 in the past 12 months.
What is Celyad SA’s market cap?
Currently, no data Available
When is Celyad SA’s upcoming earnings report date?
Celyad SA’s upcoming earnings report date is Nov 07, 2024 which is in 20 days.
How were Celyad SA’s earnings last quarter?
Celyad SA released its earnings results on Sep 13, 2024. The company reported -$0.081 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.081.
Is Celyad SA overvalued?
According to Wall Street analysts Celyad SA’s price is currently Overvalued.
Does Celyad SA pay dividends?
Celyad SA does not currently pay dividends.
What is Celyad SA’s EPS estimate?
Celyad SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Celyad SA have?
Celyad SA has 41,428,574 shares outstanding.
What happened to Celyad SA’s price movement after its last earnings report?
Celyad SA reported an EPS of -$0.081 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4%.
Which hedge fund is a major shareholder of Celyad SA?
Currently, no hedge funds are holding shares in CLYYF
---
Celyad SA Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-68.14%
12-Months-Change
Fundamentals
Return on Equity
-363.63%
Trailing 12-Months
Asset Growth
3.62%
Trailing 12-Months
Company Description
Celyad SA
Celyad SA is a clinical-stage biopharmaceutical company, which engages in the development of cell-based therapies for the treatment of cancer. It operates through the following segments: Cardiology, Immuno-oncology, and Corporate. The Cardiology segment includes the company's Cardiopoiesis, Corquest, and C-Cathez platforms. The Immuno-oncology segment consists of all assets developed based on the CAR-T cell platform. The company was founded by Michel Lussier, William Wijns, and Christian Homsy on July 24, 2007 and is headquartered in Mont-Saint-Guibert, Belgium.
---
---